so far <COMMA> the season hasn t been especially supportive of share prices <COMMA> with the outlooks from bellwether companies such as apple inc. aapl and international business machines corp. ibm disappointing expectations <PUNC>
results from pharmaceutical heavyweights are expected to be mixed as a number of companies <COMMA> including bristol-myers squibb co. bmy and pfizer inc. pfe <COMMA> have lost patent protection for their top-selling drugs <PUNC>
johnson & johnson jnj may provide a boost for the sector <COMMA> with per-share earnings expected to rise by <NUM> percent to <NUM> cents a share on an <NUM> percent rise in sales to dollar <NUM> billion <PUNC>
j.p. morgan chase & co. jpm and merrill lynch & co. mer posted a jump in profits earlier this week <PUNC>
for the week <COMMA> the dow jones industrial average dji and the s&p <NUM> finished nearly unchanged <PUNC>
the blue-chip index ended down <NUM> points at <NUM> on friday <COMMA> while the broad index rose <NUM> points to <NUM> <PUNC>
microsoft s msft earnings update is on tap for thursday <PUNC>
analysts expect its profit to fall because of the delay of software products <PUNC>
the consumer version of microsoft s office <NUM> and its vista operating system weren t ready to be sold during the holiday-shopping season <PUNC>
<PAR>
